CAS 6493-06-7

Hydroxy pentoxifylline

CAS: 6493-06-7

Formel: C₁₃H₂₀N₄O₃

Reinheit: 98%

Farbe und Form: Solid

Molekulargewicht: 280.3229

Ref: IN-DA00EB4G

(±)-Lisofylline

CAS: 6493-06-7

(±)-Lisofylline

Reinheit: ≥98%

Molekulargewicht: 280.32g/mol

Ref: 54-BUP14342

Hydroxy Pentoxifylline (rac-Lisofylline)

CAS: 6493-06-7

Formel: C₁₃H₂₀N₄O₃

Farbe und Form: White To Off-White Solid

Molekulargewicht: 280.33

Ref: 4Z-P-051

(+/-)-Lisofylline

CAS: 6493-06-7

Ref: 7W-GW8355

(±)-Lisofylline

CAS: 6493-06-7

(±)-Lisofylline is an enantiomer-specific, alkyl-substituted methylxanthine, which has specific and potent activity in down-regulating leukocyte activation.

Formel: C₁₃H₂₀N₄O₃

Reinheit: 99.87% - 99.91%

Farbe und Form: Solid

Molekulargewicht: 280.32

Ref: TM-T21729

(+/-)-Lisofylline

CAS: 6493-06-7

Formel: C₁₃H₂₀N₄O₃

Farbe und Form: Neat

Molekulargewicht: 280.32

Ref: TR-L469050

Hydroxy Pentoxifylline

CAS: 6493-06-7

Formel: C₁₃H₂₀N₄O₃

Molekulargewicht: 280.3

Ref: ST-EA-CP-P17012

(±)-Lisofylline

CAS: 6493-06-7

Reinheit: 98%

Molekulargewicht: 280.328

Ref: 10-F986978

(+/-)-Lisofylline

Kontrolliertes Produkt

CAS: 6493-06-7

Lisofylline is a chemical inhibitor of P-glycoprotein (P-gp), which belongs to the group of pharmacological agents. It is used as an active inhibitor in the treatment of bowel disease and is a low potency, non-selective squamous cell nuclear dna (SCCN) p-gp inhibitor. Lisofylline has shown to be an active inhibitor of P-gp in human colon cancer cells. Lisofylline inhibits mitochondrial membrane potential by binding to the rate constant and response element, which prevents ATP production and leads to cell death through oxidative injury.

Formel: C₁₃H₂₀N₄O₃

Reinheit: Min. 95%

Molekulargewicht: 280.32 g/mol

Ref: 3D-FL24910